[ Price : $8.95]
FDA approves Novimmunes Gamifant (emapalumab) for treating pediatric and adult patients with primary hemophagocytic lymphohistiocy...[ Price : $8.95]
The Truth in Advertising watchdog group says that many major cancer centers use misleading testimonials touting atypical results i...[ Price : $8.95]
FDA warns two companies selling dietary supplements containing tianeptine.[ Price : $8.95]
FDA classifies as Class 1 a Beckman Coulter recall of two models of flow cytometers due to an electrical circuit error.[ Price : $8.95]
FDA clears a SIG Medical 510(k) for its AdvantageRib Anterior System, intended for the fixation, stabilization, and fusion of rib ...[ Price : $8.95]
Federal Register notice: FDA determines that 47 drug products it is listing were not withdrawn from sale for reasons of safety or ...[ Price : $8.95]
FDA and Duke-Margolis Health Policy Center plan an 11/27 public meeting to seek stakeholder input on long-term solutions to addres...[ Price : $8.95]
FDA approves an expanded label for Novartis Promacta (eltrombopag) to include first-line treatment for adults and pediatric patien...